Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data
As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly…
New Analysis Shows High Rates of Skin Clearance as Measured by Absolute PASI in Patients With Moderate to Severe Plaque Psoriasis Treated With Janssen’s TREMFYA® (guselkumab)
Janssen-Cilag International NV (“Janssen”) presented a new analysis from VOYAGE 1 assessing efficacy responses based on absolute Psoriasis Area and…